Please try another search
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Name | Age | Since | Title |
---|---|---|---|
Richard A. Hausmann | 61 | 2020 | Independent Director |
Christine Dubus | - | 2020 | Independent Director |
Yves Jongen | 74 | 1991 | Founder, Chief Research Officer, MD & Executive Director |
Pierre Mottet | 59 | 1996 | Chairman of The Board |
Hedvig Hricak | 74 | 2017 | Independent Director |
Sybille Van den Hove | 56 | 2015 | Independent Director |
Marcel Miller | 68 | 2011 | Independent Director |
Olivier Legrain | 56 | 2012 | CEO, MD & Executive Director |
Muriel De Lathouwer | 52 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review